Roswell Park Comprehensive Cancer Center’s Pathology Program is expanding with the appointments of two sub-specialists — one new to Roswell Park, one an accomplished team member for many years — to leadership roles.

A new book, “Because We Care: Roswell Park in Our Community, 2019-2020.” documents the scope of Roswell Park’s educational and community outreach over the past two years — and underscores the reasons behind the cancer center’s extensive engagement.

When financial concerns weigh heavily on an individual who is in treatment for cancer, they can affect the outcome of that treatment. New research from Roswell Park provides the first evidence that a cancer patient’s level of financial worry as they begin treatment predicts how likely it is that their treatment will be successful.

A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. Their findings have been published in the journal Nature Communications.